Liver MRI is not accurate enough to definitely identify patients with iron overload.
Magnetic resonance imaging of the liver may help rule out iron overload, but is not accurate enough to definitely identify patients with the condition, according to an article published in the journal Clinical Gastroenterology and Hepatology.
Researchers from Greece sought to determine if using MRI could help identify patients with iron overload and to guide titration of chelation therapy. Their systematic review and meta-analysis was based on patients with hereditary hemochromatosis, hemoglobinopathy and myelodysplastic syndrome.
A total of 20 studies with 819 patients were chosen for the final analysis. The researchers found that sensitivity and specificity values varied greatly, ranging from 0.00 to 1.00 and from 0.50 to 1.00, respectively.
“Due to substantial heterogeneity and variable positivity thresholds, we calculated only summary receiver operating curves (and summary estimate points for studies that used the same MRI sequences). T2 spin echo and T2* gradient-recalled echo MRI sequences accurately identified patients without liver iron overload (liver iron concentration > 7 mg Fe/g dry liver weight) (negative likelihood ratios, 0.10 and 0.05 respectively),” the authors wrote. “However, these MRI sequences are less accurate in establishing a definite diagnosis of liver iron overload (positive likelihood ratio of 8.85 and 4.86 respectively).”
The authors concluded that while the MRI measurements of iron concentration in the liver may be accurate enough to rule out iron overload, the measurements were not accurate enough to definitely identify patients who may be overloaded.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.